ストックスクリーナーアプリを入手
24.21
0.88%
0.21
アフターアワーズ：
24.40
0.19
+0.78%
Tonix Pharmaceuticals Holding Corp (TNXP) 最新ニュース
13,670 Shares in Tonix Pharmaceuticals Holding Corp. $TNXP Purchased by Rhumbline Advisers - MarketBeat
Tonix advances TNX-102 SL for depression after positive FDA meeting boosts development path - Proactive financial news
What is Zacks Small Cap's Estimate for TNXP FY2025 Earnings? - MarketBeat
Tonix Pharma Licenses Rights to Lyme Disease Antibody - MSN
Daily Brief Health Care: Shandong Weigao Blood Purification Products, TYK Medicines, Butong Group, Alteogen Inc, SBC Medical Group Holdings , Achieve Life Sciences , Tonix Pharmaceuticals Holding and more - Smartkarma
Tonix gains global rights to TNX-4800, developing one-dose seasonal protection for Lyme disease - Proactive financial news
TNXP: Tonmya™ Approved by FDA… - Zacks Small Cap Research
Tonix Pharmaceuticals Holding Corp.(NasdaqCM: TNXP) added to S&P Global BMI Index - MarketScreener
Tonix plans IND filing for depression treatment after FDA meeting By Investing.com - Investing.com Nigeria
Analyst Downgrade: Is now the right time to enter Tonix Pharmaceuticals Holding CorpWeekly Risk Report & Low Drawdown Investment Strategies - خودرو بانک
Tonix plans IND filing for depression treatment after FDA meeting - Investing.com India
Tonix Pharma Completes FDA Meeting for TNX-102 SL - TipRanks
Fed Watch: Can LeddarTech Holdings Inc Equity Warrant navigate macro headwindsQuarterly Risk Review & Low Risk Entry Point Tips - خودرو بانک
Tonix Pharmaceuticals (TNXP) Advances Toward New Depression Trea - GuruFocus
Tonix Pharmaceuticals Announces Positive Pre-IND Meeting with FDA for TNX-102 SL for the Treatment of Major Depressive Disorder - The Manila Times
Tonix Pharmaceuticals Announces Plans for IND Filing of TNX-102 SL for Major Depressive Disorder Following Positive FDA Pre-IND Meeting - Quiver Quantitative
Tonix reports positive pre-IND FDA meeting for TNX-102 SL in major depressive disorder treatment - MarketScreener
Tonix Reports Positive Pre-IND FDA Meeting for TNX-102 SL in Major Depressive Disorder Treatment - TradingView
Tonix Pharmaceuticals Announces Positive Pre-IND Meeting - GlobeNewswire
FDA-Approved Fibromyalgia Drug TNX-102 SL Shows Promise for Major Depression Treatment - Stock Titan
Revolutionary 1-shot Lyme disease prevention approved - Rolling Out
Tonix Pharmaceuticals (TNXP) Gains on Lyme Disease Treatment Lic - GuruFocus
Tonix licenses monoclonal antibody for Lyme disease prevention By Investing.com - Investing.com South Africa
Tonix Pharmaceuticals gets global rights to Lyme disease treatment - Seeking Alpha
Tonix Pharmaceuticals (TNXP) Secures Rights to Potential Lyme Di - GuruFocus
Tonix Pharmaceuticals Secures Rights to Lyme Disease Prevention Candidate - MarketScreener
Tonix Pharmaceuticals announces in-licensing of worldwide rights to TNX-4800 - TipRanks
Tonix licenses monoclonal antibody for Lyme disease prevention - Investing.com
Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Seasonal Prevention of Lyme Disease (TNX-4800) - The Manila Times
Tonix Pharmaceuticals In-Licenses TNX-4800 for Lyme Disease Prevention Following Positive Phase 1 Study Results - Quiver Quantitative
Tonix Pharmaceuticals Announces In-licensing Phase - GlobeNewswire
70M Americans Could Benefit: Tonix's New Once-Yearly Antibody Shows Promise in Preventing Lyme Disease - Stock Titan
UMass Chan licenses monoclonal antibody for seasonal prevention of Lyme disease to Tonix Pharmaceuticals - UMass Chan Medical School
Is Tonix Pharmaceuticals Holding Corp stock risky to hold nowLayoff News & Safe Capital Investment Plans - خودرو بانک
Pattern recognition hints at Tonix Pharmaceuticals Holding Corp. upsideJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com
Investment Recap: Will Tonix Pharmaceuticals Holding Corp announce a stock splitPortfolio Value Summary & Verified Entry Point Detection - خودرو بانک
Aug Fed Impact: What are analysts price targets for Tonix Pharmaceuticals Holding CorpMarket Performance Recap & High Conviction Trade Alerts - خودرو بانک
What’s the RSI of Tonix Pharmaceuticals Holding Corp. stockMarket Risk Report & Momentum Based Trading Ideas - خودرو بانک
Sell Signal: Is Tonix Pharmaceuticals Holding Corp. exposed to currency risksWeekly Market Outlook & Accurate Trade Setup Notifications - khodrobank.com
Bull Bear: Does Tonix Pharmaceuticals Holding Corp offer margin of safetyRisk Management & Technical Confirmation Trade Alerts - خودرو بانک
Published on: 2025-09-15 21:26:59 - خودرو بانک
Aug EndMonth: Will Tonix Pharmaceuticals Holding Corp stock benefit from M ADividend Hike & Stepwise Entry/Exit Trade Alerts - خودرو بانک
Tonix showcases Phase 3 data for FDA-approved Tonmya at PAINWEEK 2025, eyes launch next quarter - Proactive financial news
Tonix Pharmaceuticals : September 2025 Investor Deck - MarketScreener
Published on: 2025-09-08 16:12:23 - beatles.ru
Tonix Pharmaceuticals Presents Clinical Data on Tonmya™ for the - GuruFocus
Tonix Pharmaceuticals Presents Clinical Data on Tonmya™ for the Treatment of Fibromyalgia at PAINWEEK 2025 - Yahoo Finance
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared Last Week - MSN
Combining machine learning predictions for Tonix Pharmaceuticals Holding Corp.Wall Street Watch & Safe Capital Growth Tips - Newser
Is Tonix Pharmaceuticals Holding Corp. stock entering bullish territoryJuly 2025 Review & AI Optimized Trade Strategies - Newser
Will Tonix Pharmaceuticals Holding Corp. outperform its industry peersNew Guidance & Technical Pattern Based Buy Signals - خودرو بانک
What technical models suggest about Tonix Pharmaceuticals Holding Corp.’s comebackWeekly Trade Review & Reliable Trade Execution Plans - Newser
Why is Tonix Pharmaceuticals Holding Corp. stock going downStop Loss & AI Based Buy/Sell Signal Reports - خودرو بانک
Using data models to predict Tonix Pharmaceuticals Holding Corp. stock movementSell Signal & Low Drawdown Trading Techniques - Newser
What’s the MACD signal for Tonix Pharmaceuticals Holding Corp.2025 Technical Patterns & Smart Swing Trading Alerts - خودرو بانک
Heatmap analysis for Tonix Pharmaceuticals Holding Corp. and competitorsWeekly Volume Report & Real-Time Market Sentiment Reports - Newser
3.41%
0.81%
大文字化:
|
ボリューム (24 時間):